Your browser doesn't support javascript.
loading
Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity.
Maretti-Mira, Ana C; Salomon, Matthew P; Hsu, Angela M; Dara, Lily; Golden-Mason, Lucy.
Afiliación
  • Maretti-Mira AC; USC Research Center for Liver Disease, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Salomon MP; Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Hsu AM; USC Research Center for Liver Disease, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Dara L; USC Research Center for Liver Disease, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • Golden-Mason L; Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Front Immunol ; 14: 1137034, 2023.
Article en En | MEDLINE | ID: mdl-37063898
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hepatitis C Crónica / Cirrosis Hepática Tipo de estudio: Etiology_studies Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hepatitis C Crónica / Cirrosis Hepática Tipo de estudio: Etiology_studies Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article